Почетна › Медулобластом › Florida
Kliničke studije za Медулобластом u državi Florida
6 studija za Медулобластом traži učesnike na lokacijama u državi Florida.
Gradovi u državi Florida
Zvanični tekst studije (na engleskom)
Digoxin Medulloblastoma Study
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- Nemours Children's Hospital Orlando, Orlando
- и још 2
Тражи се учесникФаза 2
12 Months – 30 Years · Оба пола · Ажурирано 4. 11. 2026. · NCT06701812Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- University of Florida Health, Gainesville
Тражи се учесникФаза 1
Узраст од 4 до 30 · Оба пола · Ажурирано 2. 11. 2026. · NCT06514898Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Orlando Health Arnold Palmer Hospital for Children, Orlando
- St. Joseph's Children's Hospital, Tampa
Тражи се учесникФаза 2
59 Months · Оба пола · Ажурирано 15. 9. 2026. · NCT05535166A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- Nemours Children's Clinic-Jacksonville, Jacksonville
- и још 7
Тражи се учесникФаза 3
Узраст од 4 до 21 · Оба пола · Ажурирано 25. 8. 2026. · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Nicklaus Children's Hospital, Miami
Тражи се учесникФаза 2
Узраст од 3 до 39 · Оба пола · Ажурирано 24. 8. 2026. · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- All Children's Hospital Johns Hopkins Medicine, St. Petersburg
- и још 1
Тражи се учесникФаза 2
До 21 година · Оба пола · Ажурирано 12. 8. 2026. · NCT04696029Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.